...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** BETonMACE Phase 3 Cardio Outcomes Trial for Apabetalone Has Reached its Targeted 250 MACE Events ** Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Pointing in the right direction & bogus Lilly

Don’t mean to be deliberately abstruse. I was sure to confirm with management that I was not given privileged information. But i don’t have enough experience to know what is normal or special disclosure with regard to biotech. Please be assured I have straight intentions and have merely shared information as truthfully as my ears heard it. 

New Message
Please login to post a reply